You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

INDOCIN SR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Indocin Sr, and when can generic versions of Indocin Sr launch?

Indocin Sr is a drug marketed by Zyla and is included in one NDA.

The generic ingredient in INDOCIN SR is indomethacin. There are fifteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the indomethacin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Indocin Sr

A generic version of INDOCIN SR was approved as indomethacin by CHARTWELL MOLECULES on August 6th, 1984.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for INDOCIN SR?
  • What are the global sales for INDOCIN SR?
  • What is Average Wholesale Price for INDOCIN SR?
Summary for INDOCIN SR
Drug patent expirations by year for INDOCIN SR
Recent Clinical Trials for INDOCIN SR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Johns Hopkins UniversityPhase 3
MetroHealth Medical CenterEarly Phase 1
Janssen Scientific Affairs, LLCPhase 2

See all INDOCIN SR clinical trials

US Patents and Regulatory Information for INDOCIN SR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zyla INDOCIN SR indomethacin CAPSULE, EXTENDED RELEASE;ORAL 018185-001 Feb 23, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for INDOCIN SR

See the table below for patents covering INDOCIN SR around the world.

Country Patent Number Title Estimated Expiration
Canada 1149742 LIBERATION ENTRETENUE D'INDOMETHACINE (SUSTAINED RELEASE INDOMETHACIN) ⤷  Sign Up
Bulgaria 60753 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.